AdaptHealth Corp. Statistics
Share Statistics
AdaptHealth Corp. has 134.56M shares outstanding. The number of shares has increased by -1.2% in one year.
Shares Outstanding | 134.56M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.95% |
Owned by Institutions (%) | n/a |
Shares Floating | 86.94M |
Failed to Deliver (FTD) Shares | 207 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 10.39M, so 7.72% of the outstanding shares have been sold short.
Short Interest | 10.39M |
Short % of Shares Out | 7.72% |
Short % of Float | 11.96% |
Short Ratio (days to cover) | 18.5 |
Valuation Ratios
The PE ratio is -1.44 and the forward PE ratio is 12.58.
PE Ratio | -1.44 |
Forward PE | 12.58 |
PS Ratio | 0.31 |
Forward PS | 0.4 |
PB Ratio | 0.67 |
P/FCF Ratio | 6.83 |
PEG Ratio | n/a |
Enterprise Valuation
AdaptHealth Corp. has an Enterprise Value (EV) of 3.20B.
EV / Earnings | -4.71 |
EV / Sales | 1 |
EV / EBITDA | -18.68 |
EV / EBIT | -5.34 |
EV / FCF | 22.31 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 1.5.
Current Ratio | 1.21 |
Quick Ratio | 1 |
Debt / Equity | 1.5 |
Total Debt / Capitalization | 59.99 |
Cash Flow / Debt | 0.22 |
Interest Coverage | -4.59 |
Financial Efficiency
Return on equity (ROE) is -0.47% and return on capital (ROIC) is -14.83%.
Return on Equity (ROE) | -0.47% |
Return on Assets (ROA) | -0.15% |
Return on Capital (ROIC) | -14.83% |
Revenue Per Employee | 299.08K |
Profits Per Employee | -63.45K |
Employee Count | 10.70K |
Asset Turnover | 0.71 |
Inventory Turnover | 23.94 |
Taxes
Income Tax | -49.00M |
Effective Tax Rate | 0.07 |
Stock Price Statistics
The stock price has increased by 23.51% in the last 52 weeks. The beta is 1.13, so AdaptHealth Corp.'s price volatility has been higher than the market average.
Beta | 1.13 |
52-Week Price Change | 23.51% |
50-Day Moving Average | 10.17 |
200-Day Moving Average | 10.38 |
Relative Strength Index (RSI) | 38.49 |
Average Volume (20 Days) | 977.78K |
Income Statement
In the last 12 months, AdaptHealth Corp. had revenue of $3.20B and earned -$678.89M in profits. Earnings per share was $-5.32.
Revenue | 3.20B |
Gross Profit | 479.56M |
Operating Income | -598.40M |
Net Income | -678.89M |
EBITDA | -171.09M |
EBIT | -598.40M |
Earnings Per Share (EPS) | -5.32 |
Balance Sheet
The company has $77.13M in cash and $2.29B in debt, giving a net cash position of -$2.22B.
Cash & Cash Equivalents | 77.13M |
Total Debt | 2.29B |
Net Cash | -2.22B |
Retained Earnings | -652.60M |
Total Assets | 4.47B |
Working Capital | 130.77M |
Cash Flow
In the last 12 months, operating cash flow was $480.67M and capital expenditures -$337.46M, giving a free cash flow of $143.20M.
Operating Cash Flow | 480.67M |
Capital Expenditures | -337.46M |
Free Cash Flow | 143.20M |
FCF Per Share | 1.07 |
Margins
Gross margin is 14.99%, with operating and profit margins of -18.7% and -21.21%.
Gross Margin | 14.99% |
Operating Margin | -18.7% |
Pretax Margin | -22.62% |
Profit Margin | -21.21% |
EBITDA Margin | -5.35% |
EBIT Margin | -18.7% |
FCF Margin | 4.47% |
Dividends & Yields
AHCO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -55.65% |
FCF Yield | 11.13% |
Analyst Forecast
The average price target for AHCO is $12, which is 25.5% higher than the current price. The consensus rating is "Buy".
Price Target | $12 |
Price Target Difference | 25.5% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | 0.78 |
Piotroski F-Score | 6 |